GLP-1 receptor agonist
Is Lixisenatide legal?
Answer
Lixisenatide is authorised or registered in 8 of the 10 registers read: United States, European Union, Canada, Switzerland, Brazil, Serbia, Singapore, Turkey.
Each row is what that country's own register said on the date shown. Not legal advice.
| Country | Status | Products on the register | Register | Read |
|---|---|---|---|---|
| United States | FDA-approved | Soliqua | Regulator FDA | 2026-10-03 |
| European Union | Authorised | Suliqua | Regulator EMA | 2026-10-03 |
| United Kingdom | Not on the register | - | Regulator MHRA | 2026-09-03 |
| Canada | Authorised | Soliqua | Regulator Health Canada | 2026-10-03 |
| Australia | Status unknown | - | TGA | Not read yet |
| Switzerland | Authorised | Suliqua | Regulator Swissmedic | 2026-10-03 |
| Brazil | Registado | Soliqua | Regulator ANVISA | 2026-10-03 |
| Serbia | Authorised | insulin glargin, liksisenatid | Regulator ALIMS | 2026-09-03 |
| Singapore | Registered | Insulin glargine&&Lixisenatide | Regulator HSA | 2026-09-03 |
| Turkey | Ruhsatli | Liksisenatid | Regulator TITCK | 2026-09-03 |
A country not listed has no register read yet; see the world map. EU decisions also apply in Iceland, Liechtenstein and Norway.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.